SlideShare a Scribd company logo
Effective Communication
with
Patients and Providers
(Including Skill Station Training Using Expert Patients)
Unit 15
HIV Care and ART: A Course for
Pharmacists by Salahadin M.Ali
2
2
Unit Learning Objectives
 Describe the team approach to HIV care and
treatment
 Explain basic principles and behaviors of ART
counseling
 Describe essential steps in communicating with
a multidisciplinary team.
 Describe essential steps in communicating with
an HIV-positive patient
 Demonstrate effective communication with
patients and providers
3
3
Team Approach in ART
 Involves pharmacist or druggist, and other
multidisciplinary team members working
together towards comprehensive patient care
 Involves information sharing between providers
and patients
 Ensures patient confidentiality
 May involve others (family members) as per the
patient’s choice.
4
Objectives of Effective Communication
 Pharmacists need to be able to share
information in order to work effectively with
patients, and the multi-disciplinary team
members.
 On a professional level with the multidisciplinary team
 With an individual patient on a level that he/she can
understand
5
5
Communicating with the Multi-
disciplinary Team Members
 Begin by identifying yourself
 Identify the patient you are to discuss
 Present the issue or concern that you have
identified
 Do not be judgmental
 Use professional rapport to gain respect
 Be prepared to discuss the issue at a
professional level
 Propose a solution
 Await feedback
6
6
Communicating with the Multi-
disciplinary Team Members (2)
 You may not always have all of the answers to
the questions that follow
 Be comfortable saying that you do not know the
answer at the moment, that you will look into it
and get back to the provider as soon as you can
 The provider will respect that you provide only
information about which you are confident
 Over time, you will build a working relationship
with the multidisciplinary team members that you
work with
7
Communicating with Patients – Importance
of Patient Counseling
 Effective patient counseling is not simply the
provision of information.
 Information is prerequisite to compliance but the
timing and organization of the message and
involvement of the patient are also critical in
determining what the patient understands and
remembers.
8
8
Communicating with Patients –
Readiness for ART
 Assess readiness to start ART
 Identify barriers to success with ART such as:
• knowledge about ART
• fears of adverse effects
• stigma
• financial concerns
• sustainability
• non-adherence
 Work with the ART team to correct barriers
before starting therapy. Every patient has
unique barriers to success
9
Communicating with Patients – Counseling
Checklist
 A patient counseling checklist (PCC-09) should
be used when counseling patients. Some of the
important counseling points are listed below:
 Name of drug
 Directions for use
 Common or severe adverse effects
 Significant drug interactions
 Storage
(Refer to the Participant Handbook to see the PCC, and the
separate job aid on counseling-Medicine Use Counseling
Guide)
10
Communicating with Patients –
Providing Information
 If written information is provided, identify
whether the patient has any learning barriers
such as low literacy
 Use pictures to communicate information
 Indicate colors of the pills to familiarize
patients with their regimen
 Ensure written information is provided in
patient’s native language
11
Communicating with Patients –
Providing Information (2)
 Ask patient to tell you how they will use the
medication
 Correct misunderstandings before they leave
 Give patients specific examples of how to
remember to take their doses: for example,
when they brush their teeth or when they wake
up their children
 Assist patients in preparing for changes in their
routine: for example, vacation or visiting family
12
12
Communicating with Patients -
Adherence
 Review need for strict adherence
 Near-perfect adherence is necessary for treatment success.
 Prevents resistance and treatment failure, which may limit future
treatment options
 Assess adherence each time patients refill their ART
 Ask questions like "When did you last miss a dose?”
rather than, “Have you missed any doses?”
 Congratulate the adherent patient
 Identify the reason for missed doses and provide
possible solutions to avoid missing doses in the future
13
13
Communicating with Patients – Clinical
and laboratory monitoring
 Review the need for ongoing clinical and
laboratory monitoring
 Success/failure of ART regimen
 Toxicities
• Detect ART adverse effects that the patient may not
feel
• Evaluate symptoms
14
Role Plays with Patients (Expert Patient
Training-EPT) (1)
 The role plays on communicating with patients
uses Expert Patient Training.
 Expert patient training uses PLHIV who are
experts in their own illness in the training of
health workers.
 These PLHIV were trained to portray patients
based on specific HIV cases that were often but
not necessarily similar to their own life
experiences.
15
Role Plays with Patients (Expert Patient
Training-EPT) (2)
 Use the 5 A’s when communicating with patients (and
also with the expert patient trainer) *:
 ASSESS
• Ask why patient came to the pharmacy
• Review the medications with the patient
• Determine whether there is an adherence problem
 ADVISE
• On prevention
• On correct treatment
• On adherence
• Provide counseling according to PCC-09
 *See the Participant Handbook for details on the 5 A’s.
16
Role Plays with Patients (Expert Patient
Training-EPT) (3)
 AGREE
 On treatment plan
 Involve patient
 ASSIST
 Provide treatment options
 Help solve treatment problems
 Provide psychological support
17
Role Plays with Patients (Expert Patient
Training-EPT) (4)
 ARRANGE
 Follow-up date(s)
 Provide treatment plan
 Complete PIS-04
 In addition to the 5 A’s the pharmacy
professional should remember the following
general points:
 Be respectful to the patient
 Use simple words
 Listen to patient
 Make sure the patient has understood all points
GALIDRA
•Greeting
•Ask
•Listen
•Identify
•Discuss
•Recommend
•Agree/Appoint
19
Role Plays with Patients (Expert Patient
Training-EPT) – (5)
 Steps:
 Demonstration of a case by a facilitator trained on
EPT with the expert patient trainer. (30 minutes)
 Role plays of trainees with the expert patient trainer.
(13 cases)
• Session 1 (Cases 1-3, ART Initiation Cases) (2 hrs)
• Session 2 (4-13, ART Follow-Up Cases) (2 hrs)
Role Plays
21
21
Role Play Scenario (1)
 A patient brings a prescription to the pharmacist
for stavudine + zidovudine + nevirapine
 Contact the patient’s physician to alert them to
the drug interaction between stavudine and
zidovudine and recommend an alternative
regimen
22
22
Role Play Scenario (2)
 A patient comes to your pharmacy and through your
conversation with him you discover that he meets the
criteria for starting Cotrimoxazole preventive therapy
(CPT). He just completed treatment for PCP 2 weeks
ago. He is not currently taking Cotrimoxazole for CPT
 Ask the patient if he has had Cotrimoxazole in the past
and try to find out if he has any drug allergies. Then,
contact the patient’s nurse/physician to suggest that the
patient be started on Cotrimoxazole DS daily for CPT, if
appropriate
23
23
Role Play Scenario (3)
 A patient comes to the pharmacy and tells you
that he has been feeling itchy. He pulls up his
shirt and shows you a rash on his skin
 You look at his medication profile and see that
he started the following regimen 3 weeks ago:
stavudine + lamivudine + nevirapine
 You have established that the patient has a mild
rash
 Contact the patient’s nurse or physician and
pass on the information about the Nevirapine
drug reaction
24
24
Role Play Scenario (4)
 A patient comes to your pharmacy with
prescriptions for:
Lopinavir/ritonavir, Stavudine, Lamivudine
Rifampin, Isoniazid & Pyridoxine, Pyrazinamide, Ethambutol
 You remember the drug interaction between
Lopinavir/ritonavir and Rifampin and recognize that
these two drugs should not be combined together
 Contact the patient’s physician/nurse with this
information. Recommend an alternative regimen (or
beginning ART after TB 2-month initiation)
25
Role Play Scenarios 5-17
 These role plays use the expert patient training
(EPT) cases.
 See the separate EPT Amharic version cases
(Cases 1-13)
26
26
Key Points
 A team approach to HIV care and treatment is an
effective way to care for HIV-positive patients
 Good communication with providers and patients
is essential for successful HIV care and
treatment
 Pharmacists need to counsel patients on ART
readiness, ART information, and the importance
of adherence and ongoing monitoring
 Use the principle of 5 A’s when communicating
with patients

More Related Content

Similar to Communication ppt.ppt

PATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLSPATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLS
VaishnaviJanjal
 
therapy-1.pptx for pharmacy third year students
therapy-1.pptx for pharmacy third year studentstherapy-1.pptx for pharmacy third year students
therapy-1.pptx for pharmacy third year students
kalaman3
 
Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4
Sabih Huq
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Areej Abu Hanieh
 
Presntation communication skill for phrmacist
Presntation communication skill for phrmacistPresntation communication skill for phrmacist
Presntation communication skill for phrmacistyasser maksoud
 
Patient consultancy 23082016
Patient consultancy 23082016 Patient consultancy 23082016
Patient consultancy 23082016
Dr. Ali Uzair MD (GOLD MEDALIST)
 
9. Counselling.ppt
9. Counselling.ppt9. Counselling.ppt
9. Counselling.ppt
AbwoneKenneth
 
Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...
MerrinJoseph1
 
Communication in drug administration
Communication in drug administrationCommunication in drug administration
Communication in drug administration
Prof Dr Sonopant Joshi
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
Arghya Chowdhury
 
Patient education and counselling
Patient education and  counsellingPatient education and  counselling
Patient education and counselling
Zainab&Sons
 
Modern dispensing aspects
Modern dispensing aspectsModern dispensing aspects
Modern dispensing aspects
Aimen Salman
 
Ward round kosey
Ward round koseyWard round kosey
Ward round kosey
sopi_1234
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
Sujit Karpe
 
Aastha
AasthaAastha
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
Lipanjali Badhei
 
patientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdfpatientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdf
HasmukhPatel63
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
Jabir Jabir
 
Patient counseling
Patient counselingPatient counseling
Patient counseling
Maniz Joshi
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
Siddhantkapil2
 

Similar to Communication ppt.ppt (20)

PATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLSPATIENT COUNSELLING AND COMMUNICATION SKILLS
PATIENT COUNSELLING AND COMMUNICATION SKILLS
 
therapy-1.pptx for pharmacy third year students
therapy-1.pptx for pharmacy third year studentstherapy-1.pptx for pharmacy third year students
therapy-1.pptx for pharmacy third year students
 
Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4Communicating prescribing decisions v1.4
Communicating prescribing decisions v1.4
 
Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project Code of Ethics for Pharmacists and Pharmacy Technicans Project
Code of Ethics for Pharmacists and Pharmacy Technicans Project
 
Presntation communication skill for phrmacist
Presntation communication skill for phrmacistPresntation communication skill for phrmacist
Presntation communication skill for phrmacist
 
Patient consultancy 23082016
Patient consultancy 23082016 Patient consultancy 23082016
Patient consultancy 23082016
 
9. Counselling.ppt
9. Counselling.ppt9. Counselling.ppt
9. Counselling.ppt
 
Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...Patient counselling ,steps of patient ppunseling,communication skill in patie...
Patient counselling ,steps of patient ppunseling,communication skill in patie...
 
Communication in drug administration
Communication in drug administrationCommunication in drug administration
Communication in drug administration
 
Patient counceling arghya
Patient counceling arghyaPatient counceling arghya
Patient counceling arghya
 
Patient education and counselling
Patient education and  counsellingPatient education and  counselling
Patient education and counselling
 
Modern dispensing aspects
Modern dispensing aspectsModern dispensing aspects
Modern dispensing aspects
 
Ward round kosey
Ward round koseyWard round kosey
Ward round kosey
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 
Aastha
AasthaAastha
Aastha
 
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPMMEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
MEDICATION ADHERENCE.pptx D. Pharm 2nd Year CPM
 
patientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdfpatientcounselling-150101104720-conversion-gate01 (1).pdf
patientcounselling-150101104720-conversion-gate01 (1).pdf
 
Patient counselling
Patient counsellingPatient counselling
Patient counselling
 
Patient counseling
Patient counselingPatient counseling
Patient counseling
 
Patient counselling
Patient counselling Patient counselling
Patient counselling
 

More from Haramaya University

PHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.pptPHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.ppt
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
Haramaya University
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
Haramaya University
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
Haramaya University
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
Haramaya University
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
Haramaya University
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
Haramaya University
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdfTirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Haramaya University
 
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdfRenal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Haramaya University
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
Haramaya University
 

More from Haramaya University (20)

PHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.pptPHARMACEUTICAL ANALYSIS-II.ppt
PHARMACEUTICAL ANALYSIS-II.ppt
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
PHARMACOLOGY I.pptx
PHARMACOLOGY I.pptxPHARMACOLOGY I.pptx
PHARMACOLOGY I.pptx
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
 
DRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdfDRUG INFORMATION CENTER.pdf
DRUG INFORMATION CENTER.pdf
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
 
INTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.pptINTEGRATED THERAPEUTICS I.ppt
INTEGRATED THERAPEUTICS I.ppt
 
INTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptxINTEGRATED THERAPEUTICS I.pptx
INTEGRATED THERAPEUTICS I.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
UPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptxUPTODATE INFORMATION.pptx
UPTODATE INFORMATION.pptx
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdfTirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
Tirzepatide versus Semiglutide Once Weekly in Patients with Type 2 Diabetes.pdf
 
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdfRenal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
Renal and Cardiovascular Outcomes with Efpeglenatide in Type 2 Diabetes.pdf
 
LITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptxLITERATURE EVALUATION.pptx
LITERATURE EVALUATION.pptx
 

Recently uploaded

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 

Communication ppt.ppt

  • 1. Effective Communication with Patients and Providers (Including Skill Station Training Using Expert Patients) Unit 15 HIV Care and ART: A Course for Pharmacists by Salahadin M.Ali
  • 2. 2 2 Unit Learning Objectives  Describe the team approach to HIV care and treatment  Explain basic principles and behaviors of ART counseling  Describe essential steps in communicating with a multidisciplinary team.  Describe essential steps in communicating with an HIV-positive patient  Demonstrate effective communication with patients and providers
  • 3. 3 3 Team Approach in ART  Involves pharmacist or druggist, and other multidisciplinary team members working together towards comprehensive patient care  Involves information sharing between providers and patients  Ensures patient confidentiality  May involve others (family members) as per the patient’s choice.
  • 4. 4 Objectives of Effective Communication  Pharmacists need to be able to share information in order to work effectively with patients, and the multi-disciplinary team members.  On a professional level with the multidisciplinary team  With an individual patient on a level that he/she can understand
  • 5. 5 5 Communicating with the Multi- disciplinary Team Members  Begin by identifying yourself  Identify the patient you are to discuss  Present the issue or concern that you have identified  Do not be judgmental  Use professional rapport to gain respect  Be prepared to discuss the issue at a professional level  Propose a solution  Await feedback
  • 6. 6 6 Communicating with the Multi- disciplinary Team Members (2)  You may not always have all of the answers to the questions that follow  Be comfortable saying that you do not know the answer at the moment, that you will look into it and get back to the provider as soon as you can  The provider will respect that you provide only information about which you are confident  Over time, you will build a working relationship with the multidisciplinary team members that you work with
  • 7. 7 Communicating with Patients – Importance of Patient Counseling  Effective patient counseling is not simply the provision of information.  Information is prerequisite to compliance but the timing and organization of the message and involvement of the patient are also critical in determining what the patient understands and remembers.
  • 8. 8 8 Communicating with Patients – Readiness for ART  Assess readiness to start ART  Identify barriers to success with ART such as: • knowledge about ART • fears of adverse effects • stigma • financial concerns • sustainability • non-adherence  Work with the ART team to correct barriers before starting therapy. Every patient has unique barriers to success
  • 9. 9 Communicating with Patients – Counseling Checklist  A patient counseling checklist (PCC-09) should be used when counseling patients. Some of the important counseling points are listed below:  Name of drug  Directions for use  Common or severe adverse effects  Significant drug interactions  Storage (Refer to the Participant Handbook to see the PCC, and the separate job aid on counseling-Medicine Use Counseling Guide)
  • 10. 10 Communicating with Patients – Providing Information  If written information is provided, identify whether the patient has any learning barriers such as low literacy  Use pictures to communicate information  Indicate colors of the pills to familiarize patients with their regimen  Ensure written information is provided in patient’s native language
  • 11. 11 Communicating with Patients – Providing Information (2)  Ask patient to tell you how they will use the medication  Correct misunderstandings before they leave  Give patients specific examples of how to remember to take their doses: for example, when they brush their teeth or when they wake up their children  Assist patients in preparing for changes in their routine: for example, vacation or visiting family
  • 12. 12 12 Communicating with Patients - Adherence  Review need for strict adherence  Near-perfect adherence is necessary for treatment success.  Prevents resistance and treatment failure, which may limit future treatment options  Assess adherence each time patients refill their ART  Ask questions like "When did you last miss a dose?” rather than, “Have you missed any doses?”  Congratulate the adherent patient  Identify the reason for missed doses and provide possible solutions to avoid missing doses in the future
  • 13. 13 13 Communicating with Patients – Clinical and laboratory monitoring  Review the need for ongoing clinical and laboratory monitoring  Success/failure of ART regimen  Toxicities • Detect ART adverse effects that the patient may not feel • Evaluate symptoms
  • 14. 14 Role Plays with Patients (Expert Patient Training-EPT) (1)  The role plays on communicating with patients uses Expert Patient Training.  Expert patient training uses PLHIV who are experts in their own illness in the training of health workers.  These PLHIV were trained to portray patients based on specific HIV cases that were often but not necessarily similar to their own life experiences.
  • 15. 15 Role Plays with Patients (Expert Patient Training-EPT) (2)  Use the 5 A’s when communicating with patients (and also with the expert patient trainer) *:  ASSESS • Ask why patient came to the pharmacy • Review the medications with the patient • Determine whether there is an adherence problem  ADVISE • On prevention • On correct treatment • On adherence • Provide counseling according to PCC-09  *See the Participant Handbook for details on the 5 A’s.
  • 16. 16 Role Plays with Patients (Expert Patient Training-EPT) (3)  AGREE  On treatment plan  Involve patient  ASSIST  Provide treatment options  Help solve treatment problems  Provide psychological support
  • 17. 17 Role Plays with Patients (Expert Patient Training-EPT) (4)  ARRANGE  Follow-up date(s)  Provide treatment plan  Complete PIS-04  In addition to the 5 A’s the pharmacy professional should remember the following general points:  Be respectful to the patient  Use simple words  Listen to patient  Make sure the patient has understood all points
  • 19. 19 Role Plays with Patients (Expert Patient Training-EPT) – (5)  Steps:  Demonstration of a case by a facilitator trained on EPT with the expert patient trainer. (30 minutes)  Role plays of trainees with the expert patient trainer. (13 cases) • Session 1 (Cases 1-3, ART Initiation Cases) (2 hrs) • Session 2 (4-13, ART Follow-Up Cases) (2 hrs)
  • 21. 21 21 Role Play Scenario (1)  A patient brings a prescription to the pharmacist for stavudine + zidovudine + nevirapine  Contact the patient’s physician to alert them to the drug interaction between stavudine and zidovudine and recommend an alternative regimen
  • 22. 22 22 Role Play Scenario (2)  A patient comes to your pharmacy and through your conversation with him you discover that he meets the criteria for starting Cotrimoxazole preventive therapy (CPT). He just completed treatment for PCP 2 weeks ago. He is not currently taking Cotrimoxazole for CPT  Ask the patient if he has had Cotrimoxazole in the past and try to find out if he has any drug allergies. Then, contact the patient’s nurse/physician to suggest that the patient be started on Cotrimoxazole DS daily for CPT, if appropriate
  • 23. 23 23 Role Play Scenario (3)  A patient comes to the pharmacy and tells you that he has been feeling itchy. He pulls up his shirt and shows you a rash on his skin  You look at his medication profile and see that he started the following regimen 3 weeks ago: stavudine + lamivudine + nevirapine  You have established that the patient has a mild rash  Contact the patient’s nurse or physician and pass on the information about the Nevirapine drug reaction
  • 24. 24 24 Role Play Scenario (4)  A patient comes to your pharmacy with prescriptions for: Lopinavir/ritonavir, Stavudine, Lamivudine Rifampin, Isoniazid & Pyridoxine, Pyrazinamide, Ethambutol  You remember the drug interaction between Lopinavir/ritonavir and Rifampin and recognize that these two drugs should not be combined together  Contact the patient’s physician/nurse with this information. Recommend an alternative regimen (or beginning ART after TB 2-month initiation)
  • 25. 25 Role Play Scenarios 5-17  These role plays use the expert patient training (EPT) cases.  See the separate EPT Amharic version cases (Cases 1-13)
  • 26. 26 26 Key Points  A team approach to HIV care and treatment is an effective way to care for HIV-positive patients  Good communication with providers and patients is essential for successful HIV care and treatment  Pharmacists need to counsel patients on ART readiness, ART information, and the importance of adherence and ongoing monitoring  Use the principle of 5 A’s when communicating with patients

Editor's Notes

  1. Notes: This unit should take approximately 5:15 hours to complete. Step 1: Communicating with Patients and Providers (Slides 2-18) – 20 minutes Step 3: Role Play Exercises (Communicating with physicians and nurses) (Slides 19-23) – 45 minutes Step 4: Role Play Exercises with Expert Patient Trainers (2 sessions of 2 hours each) – 4 hours Step 4: Key Points, Questions (Slide 25) – 10 minutes
  2. Note: Step 1: Communicating with Patients and Providers (Slides 2-18) – 20 minutes
  3. Notes: On a professional level with the multidisciplinary team members. For example, “The combination of ddI and D4T increases the risk of pancreatitis and peripheral neuropathy. Therefore it is not recommended that they be used together.” With an individual patient on a level that he/she can understand. For example, “D4T may cause peripheral neuropathy. This would feel like tingling in your hands and or feet. It may be painful.”
  4. Note: You are the expert on drug therapy, but patients are experts on their daily routines, how they understand their illness and its treatment, and whether they anticipate any problems taking the medicine as prescribed. Each of these points needs to be assessed if counseling is to be effective.
  5. Note: Other factors which should be considered when preparing to start ART are fasting, going for holy water, traditional healers, substance abuse (Chat chewing, cigarette smoking, alcohol abuse), work schedule (may interfere with dosing schedule), family disclosure, and distance between patient’s home and the health institution.
  6. Notes: When a patient comes back for a refill, you don’t have to review all 5 points. Instead, ask questions like: How are things going? Are you tolerating the medication? Has your provider made any changes to your regimen since you were here last? Form groups and discuss on the Patient Counseling Checklist (PCC 09) that is found in the participant handbook.
  7. Note: Tell patients how to handle missed doses (Half Way Rule).
  8. Notes: By phrasing the question, “When did you last miss a dose?” you can tell the patient that it is realistic to miss a dose from time to time. If you ask, “Have you missed any doses?” a patient may say, “no,” because patients often want to please the health-care worker.
  9. Notes: ASSESS Review the medications with the patient and their treatment supporter. Determine whether there is an adherence problem. Ask questions in a respectful and non-judgmental way. Ask in a way that makes it easier for patients to be truthful: • "Many patients have trouble taking their medications. What trouble are you having?" • "Can you tell me when and how you take each pill?" • "When is it most difficult for you to take the pills?" • "It is sometimes difficult to take the pills every day and on time. How many have you missed in the last 4 days (insert agreed time period)?" Ask about the common and locally important factors that may interfere with adherence. Ask about stigma related to taking the pills. Count pills. How many pills forgotten yesterday, last 3 days, last month? If poor adherence, determine what the problem is: • Side effects? • Simply forgot? • Ran out of pills? • Which dose missed: morning or evening? Why? • Cost? • Reminds you of HIV? • Misunderstood? (explain, use aids) • Changed work situation? • Not comfortable taking medication around others? • Stigma? • Different timing when away from home or holiday, travel, weekend? • Seldom at home and disorganized? • Transport problems • Problems with diet (food availability)? • Another medical problem? • Screen for excess alcohol use and depression, and treat, if present. • Other locally common constraints: __________________ , __________________ , ______________________ ADVICE Reinforce the information given before. Give additional information that may help with adherence problem. Advise on any suggested changes in the regimen (after consulting with clinician). (If treatment needs to be stopped, or if patient decides to stop a drug, stop all medications at once and consult with clinician. Usually side effects require only changing one drug, not stopping—consult with clinician if this is necessary).
  10. Notes: AGREE Agree on any changes in Treatment Plan and solutions to adherence problems (if present). Discuss the agreements you have reached and check for their commitment. ASSIST Provide adherence support. Reinforce interventions which match the patient’s needs and adherence problems, if present. Make sure that the patient has: • Plan to link taking medications with daily events such as meals. • Any device or skills (e.g. how to use a diary) that s/he needs. Make sure patient has the support s/he needs: • Get help from treatment buddy, other family and friends or peers. • Help patient and treatment supporter to find solutions. If adherence problem: • Get help! Call for advice or refer back sooner but do not "just refer". • Link with home-based care for help and home visits. • Seek help from district clinic adherence staff if regimen is too complicated or not tolerated or low adherence. If repeated missed doses, use special interventions (home visit, etc).
  11. Notes: ARRANGE Record adherence estimate on patient’s card. Arrange for refills. Arrange for next follow-up visits: • in clinic • home visits Make sure that the patient and supporter understand the follow up plan and how to contact the clinic team if there is a problem.
  12. Notes: Step 3: Role Play Exercises (Communicating with physicians and nurses) (Slides 19-23) – 45 minutes Step 4: Role Play Exercises with Expert Patient Trainers (2 sessions of 2 hours each) – 4 hours What is Role Play? Class participants play the role of a pharmacist, or other person in a practice setting. Participants pretend to have a conversation with a health professional or patient about a particular issue. Role playing allows you to see how you might react in a situation before it arises. Divide into small groups (5-8 per group) Select two participants to do the role play for each group One person will be the pharmacist One person will be the patient OR the physician/nurse Participants should switch roles after each role play so that everybody has a chance to play the pharmacist at least twice. Select one participant to provide feedback to the pharmacist about how the counseling session went (e.g., language, professionalism, information provided, empathy, etc.) Begin with a positive comment, such as “I liked the way you approached the problem.” Follow with suggestions for improvement, such as “Next time, you might try to slow down your speech.” End with a positive comment, such as “You identified a potentially negative drug interaction and corrected the problem.” Avoid negative feedback that the individual cannot change (e.g., the tone of their voice) Instead, provide constructive criticism that can help them improve their skills You may share an experience that you have had to demonstrate your point
  13. Step 4: Key Points, Questions (Slide 25) – 10 minutes